KKR announced an agreement to invest in Catalio Capital Management, a multi-strategy investment firm focused on biomedical technology and health care companies. The addition of new capital is expected to accelerate Catalio’s growth trajectory and talent acquisition, as well as anchor its investment strategies. Pursuant to the agreement, KKR is acquiring a minority economic stake in Catalio and will invest in Catalio’s funds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on KKR:
- KKR, Flerie partner to form pharma services platform and invest in companies
- France reviewing Circor buyout over defense concerns, Bloomberg says
- KKR call volume above normal and directionally bullish
- KKR (NYSE:KKR) Set to Make Major Bid for Telecom Italia’s Grid
- KKR price target lowered to $74 from $76 at BofA